Press Releases

GlobeNewswire, Inc.

-- $30 million financing enables execution of U.S. commercial strategy for the FemaSeed® fertility portfolio and advancement of the FemBloc® clinical and regulatory program toward U.S. approval -- ATLANTA, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Femasys...

GlobeNewswire, Inc.

NESS ZIONA, Israel, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, today reported financial results for the second quarter and...

GlobeNewswire, Inc.

Second quarter revenue nearly doubled compared to the first quarter of 2026 Drone revenue increased 67% sequentially from the first quarter of 2026 Sensor revenue increased 112% sequentially from the first quarter of 2026 Allen, Texas production...

GlobeNewswire, Inc.

Successfully transitioned SIL204 from regulatory preparation into an active Phase 2/3 clinical program in locally advanced pancreatic cancer, with trial initiation at Tel Aviv Sourasky Medical Center in July 2026 following clinical trial...

GlobeNewswire, Inc.

Revenue increase and operating performance improve as capital-efficient distribution strategy gains momentum Strengthened balance sheet and expanding rehabilitation platform support continued commercial execution HUDSON, Mass. and YOKNEAM ILLIT,...

GlobeNewswire, Inc.

$1.7 Million First-Half Revenue, Up 19% Year Over Year $1.2 Million Second-Quarter Revenue as U.S. DoW POR Deliveries Moved to a Monthly Cadence New Products Launch Followed by Design Wins and Initial Orders for MultiBand & Tactical Expanding...

GlobeNewswire, Inc.

Ramat Gan, Israel, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (NASDAQ/TASE: ODYS), a leader in AI-powered visual sensing and predictive maintenance (PdM) solutions for the aerospace, defense, and industrial markets, today announces its...

GlobeNewswire, Inc.

Expanded 2026 Israel Electric Corporation IC Drone Grid-Maintenance Season Commenced; Purchase Order on Track to Generate the Expected More Than $1 Million in Revenue During 2026 New Bird of Prey Order Received Through Elbit Systems, with...

GlobeNewswire, Inc.

EscharEx® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027 Master Services Agreement Signed with Vericel Under its BARDA Contract for NexoBrid® Second Quarter Revenue of $3.1...

GlobeNewswire, Inc.

JERUSALEM, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced its intention to offer its...

GlobeNewswire, Inc.

Nexera holds approximately 70.82% of the issued and outstanding common shares of Fort Technology, valued at approximately US$13.6 million Tel Aviv, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) -- -- Nexera Technologies Ltd (“Nexera” or the “Company”)...

GlobeNewswire, Inc.

TYLER, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that it has entered into a securities purchase agreement (“ELOC”) with an...

GlobeNewswire, Inc.

JUPITER, Fla., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), d/b/a Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered,...

GlobeNewswire, Inc.

Record second quarter 2026 revenue increased 35% to $17.1 million, compared with Q2 2025 Adjusted EBITDA more than doubled year-over-year to $3.5 million, with margin expanding to 20% Remaining performance obligations grew 30% year-over-year to...

GlobeNewswire, Inc.

REHOVOT, Israel, and HOBOKEN, N.J., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the...

GlobeNewswire, Inc.

Delivered record Q2 Contribution ex-TAC and programmatic revenue, highlighted by all-time record quarterly CTV revenue; raises full-year 2026 Contribution ex-TAC and programmatic revenue guidance for the third time this year Advanced nexAI through...

GlobeNewswire, Inc.

Record-High First Half Revenues of $100.2 Million, up 13% Year-over-Year; Record-High First Half Adjusted EBITDA of $25.7 Million, a 26% margin of Revenues, up 14% Year-over-Year Record-High Second Quarter Revenues of $54.9 Million, up 23%...

GlobeNewswire, Inc.

FDA Accepted D-PLEX₁₀₀ NDA with Priority Review; PDUFA Goal Date of November 28, 2026, Approximately One Quarter Ahead of Previously Communicated Guidance Exclusive U.S. and Canada Commercialization Partnership with Azurity Pharmaceuticals; $30...

GlobeNewswire, Inc.

– Breakthrough results from V012 dialysis access Phase 3 study, where ATEV was observed to outperform AV fistula; supplemental Biologic License Application (sBLA) for dialysis access to be filed with the Food and Drug Administration (FDA) during...

GlobeNewswire, Inc.

NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pathward Financial, Inc. (“Pathward” or the “Company”) (NASDAQ: CASH). Such investors are advised to contact Danielle Peyton at...